Related Experiment Video
Updated: Oct 10, 2025
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Temporal Brain MRI Changes From Extrapontine Myelinolysis to Central Pontine Myelinolysis: A Case Report
ChengYang Lee1, ChingChung Ko1
1Medical Imaging, Chi Mei Medical Center, Tainan City, TWN.
Abstract:
We present a case that was initially misdiagnosed as drug-related extrapyramidal side effect. However, after the suspected causative drugs were withdrawn, the patient's condition did not improve. Neuroimaging revealed osmotic demyelination syndrome with a temporal pattern of change from extrapontine myelinolysis to central pontine myelinolysis. Given the limited literature on this rare condition, further research to support clinical diagnosis and treatment is needed.
Insights
A rare case initially misdiagnosed as a drug side effect was found to be osmotic demyelination syndrome. Neuroimaging showed a progression from extrapontine to central pontine myelinolysis, highlighting the need for better diagnostic and treatment strategies.
Area of Science:
- Neurology
- Radiology
Background:
- Extrapyramidal side effects from drugs can mimic various neurological conditions.
- Accurate diagnosis is crucial for appropriate patient management.
Observation:
- A patient's condition persisted despite withdrawal of suspected causative drugs.
- Neuroimaging demonstrated a characteristic temporal progression of osmotic demyelination syndrome.
Findings:
- The case presented with a unique pattern of osmotic demyelination syndrome, evolving from extrapontine to central pontine myelinolysis.
- This highlights the diagnostic challenges in differentiating drug-induced effects from osmotic demyelination syndrome.
Implications:
- Further research is essential to improve the clinical diagnosis of osmotic demyelination syndrome.
- Enhanced understanding may lead to novel therapeutic approaches for this rare neurological disorder.
